Approval · Notice of Compliance 7665 · 2005
ENBREL: Notice of Compliance 7665
Issued December 20, 2005
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 7665
- Date
- December 20, 2005
- Company
- Immunex CorporationThousand Oaks, California, United States
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New indication - treatment of chronic plaque psoriasis / new formulation / new strength
- Therapeutic class
- Biological response modifier
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ENBREL | Not yet assigned | — |
| ENBREL | 02274728 | Marketed |
Medicinal ingredients
- ETANERCEPT 25 MG per VIAL
- ETANERCEPT 50 MG per ML